Previous Page  20 / 22 Next Page
Information
Show Menu
Previous Page 20 / 22 Next Page
Page Background

Page 59

conferenceseries

.com

Volume 8, Issue 10 (Suppl)

J Diabetes Metab

ISSN: 2155-6156 JDM, an open access journal

Herbal Diabetes 2017

November 02-04, 2017

November 02-04, 2017 Bangkok, Thailand

23

rd

International Conference on

Herbal and Alternative Remedies for

Diabetes and Endocrine Disorders

The anti-diabetic effect of

Lupine turmos

compared with anti-diabetic drug Glibenclamide

Laila E Taha

Alzaiem Alazhari University, Sudan

Statement of the Problem:

The problem of the study lied behind the fact that Sudanese diabetic patients are using some plants

as a treatment, without any experimental data on their biological effects, their suitable dose and their role in diabetic treatment.

Some diabetic patients are suffering from side effects of anti-diabetic drugs.

Purpose:

To determine the biological effects of

Lupine turmos

which is used traditionally by diabetic Sudanese patients

comparing with anti-diabetic drug Glibenclamide.

Methodology:

The essays of the present study were conducted on albino rats which obtained from the faculty of pharmacy,

University of Khartoum, Sudan. 30 albino rats of either sex weighing (135-250 g) and aged two months were used. 6 animals

served as control, 6 animals were treated with anti-diabetic drug (Glibenclamide10 gm/kg-body-weight) and 18 animals (three

groups N=6) were administered with three different doses (200, 400 and 800 mg/kg-b.w) respectively. Blood specimens were

collected from each group and serum levels of blood glucose, lipid profile and α-amylase concentrations were estimated.

Findings:

The results shows an insignificant difference between the means of blood glucose in the two treated groups, group

(4) which was treated with (400 mg/kg-b.w)

Lupine turmos

aqueous extract (blood glucose-111.9 mg/dl) and group (2) with

(10 mg/kg-b.w) Glibenclamide (blood glucose-98.416 mg/dl). Cholesterol and triglycerides of treated groups were the same as

group (3) with (10 mg/kg-b.w) Glibenclamide, there was no significant difference between two groups and control group. The

aqueous extract of the plant inhibited α-amylase enzyme activity at a dose (200 mg/kg-b.w), in group (3) versus group (2) with

Glibenclamide drug there was no significant difference between two groups (p≤0.05).

Conclusion & Significance:

It can be concluded from this study that

Lupine turmos

aqueous extract have a hypoglycemic effect

by reducing both blood glucose and α-amylase enzyme without any side effects.

laila3md@gmail.com

J Diabetes Metab 2017, 8:10 (Suppl)

DOI: 10.4172/2155-6156-C1-073